(Date:10/6/2008)... Lutherville-based civil litigation and ...r-Thompson Co. after jury awarded $3.2 million to ... Lutherville, Maryland ((Lexis Nexis) October ....mmplegal.com/ [Miller, Murtha & Psoras] have ... on behalf of a Maryland welder who was awarded mo...
(Date:10/5/2008)...ts to include more healthy choices at schools, sta...ruit juices are giving students more calories tha...tudy, a nationwide effort led by Temple University...ool students, found vending machines beverages had...es, and snacks over 200 hundred calories. , The ...
(Date:10/5/2008)... MA...Free prescription drug samples distributed t...physicians from Cambridge Health Alliance and Hasb...rst to look at free drug sample use among children... . , The authors, who also serve as researchers...edical School of Brown University, found that chil...
(Date:10/5/2008)...alif. Hospitalized kids with painful ailments fro...ng, painkilling drugs known as opiates. The medica...ects. Constipation, for instance, is one side effe...ild,s hospital stay. , "No parent wants their ch...id Paul Sharek, MD, MPH, medical director for qual...
Breaking Medicine News(10 mins):Health News:Miller, Murtha & Psoras Secures Multimillion-Dollar Settlement for Victim of Industrial Accident at Bethlehem Steel 2Health News:School vending machines dole out excess calories, fat 2Health News:Free drug samples carry risks for children 2Health News:Major study of opiate use in children's hospitals provides simple steps to alleviate harm 2Health News:Major study of opiate use in children's hospitals provides simple steps to alleviate harm 3(Date:10/6/2008)..., Design Concept of Other Product - Company,s Bio... Symposium, HONG KONG, Oct. 6 /- Dat...st pro-healing stent, OrbusNeich,s Genous Bio-engi... Transcatheter Cardiovascular,Therapeutics symposi...ter, M.D., Ph.D., of the Academic Medical Center i...
(Date:10/3/2008)... REYKJAVIK, Iceland, Oct. 3 /PRNewswire-FirstCa...unced the filing of an investigational new drug,(I...ll-molecule modulator,of phosphodiesterase 4 (PDE4... The compound is being developed as a new and pote...mory loss and cognitive deficits associated,with A...
(Date:10/2/2008)... PARIS, October 2 /- Pharmaleads h...PS) the authorization to perform a single,ascendin...for oral,treatment of neuropathic pain., Neuropat...n estimated,prevalence in the world,s population o...with many causes such as shingles, herpes, diabete...
(Date:10/2/2008)... OXFORD, England, October 2 /- Cir...focused on the fields of allergy and critical,care...clinical study of its,ToleroMune(R) technology in ...tive results achieved in an earlier phase II study...ts of the ToleroMune approach to allergy,desensiti...
Breaking Medicine Technology:Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology 2Nuclear stress test can detect more than blockages 23901 1Nuclear stress test can detect more than blockages 23901 2Nuclear stress test can detect more than blockages 23901 3Exhausted B cells fail to fight HIV 4007 1Kroll Fraud Solutions Launches 26quot 3BHandling Sensitive Patient Information in the Healthcare Workplace 3A An eLearning Course for Safeguarding Pa 23897 1Kroll Fraud Solutions Launches 26quot 3BHandling Sensitive Patient Information in the Healthcare Workplace 3A An eLearning Course for Safeguarding Pa 23897 2Creator of Recon Moutaineers Tactical Combat Casualty Care Bag Praises Combat Lifesavers 23892 1Creator of Recon Moutaineers Tactical Combat Casualty Care Bag Praises Combat Lifesavers 23892 2.../ - ConjuChem Biotechnologies (TSX:CJB),today ann...C(TM):Exendin-4 Albumin Conjugate for the treatme...h Scientific,Sessions of the American Diabetes As...icago, IL. The ADA,s annual,Scientific Sessions me...care professionals involved in diabetes research,...
...007 /PRNewswire-FirstCall/ -- Orexigen(TM),Therape...on the,treatment of central nervous system disorde...ed that the Company will present data,about its le...effect on markers of cardiovascular disease (visce... insulin-resistance. The,findings come from additi...
Other Medicine Technology:ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin,Conjugate Data Presented at American Diabetes Association Annual,Meeting 2ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin,Conjugate Data Presented at American Diabetes Association Annual,Meeting 3Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 2Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 3Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used percutaneously to direct a .038 inch (0.97 mm) diameter wire guide to a specific renal area. The Torcon® catheter has an inner stainless steel braid which imparts torque control to the cathe
Used when establishing a percutaneous tract for nephrostomy drainage. The guide has a stiff shaft and a gradual transition to a very flexible distal tip. Supplied sterile in peel-open packages. Inten
Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: